Adoptive Cell Transfer |
ACT |
Adverse Event |
AE |
Angiopoietin 2 |
ANG2 |
Antigen-Presenting Cell |
APC |
Barcelona Clinic HCC |
BCLC |
Chimeric Antigen Receptor T Cell |
CAR-T Cell |
Cytokine-Induced Killer Cell |
CIK |
Cytotoxic T-Lymphocyte |
CTL |
Cytotoxic T Lymphocyte-Associated Antigen 4 |
CTLA-4 |
Dendritic Cell |
DC |
Disease Control Rate |
DCR |
ECOG Performance Status |
ECOG |
Hepatocellular Carcinoma |
HCC |
Immune Checkpoints |
ICPs |
Intercellular adhesion molecule 1 |
ICAM1 |
Lymphocyte Activation Gene-3 |
LAG-3 |
Major Histocompatibility Complex Class 1 |
MHC-1 |
Median Time to Progression |
mTTP |
Monoclonal Antibody |
mAb |
Natural Killer Cell |
NK |
Notch pathway-related genes |
NPRGs |
Objective Response Rate |
ORR |
Overall Survival |
OS |
Programmed Cell Death 1 |
PD-1 |
Progression-Free Survival |
PFS |
Regulatory T Cell |
Treg |
Stem/progenitor cells |
FLSPCs |
T Cell Receptor |
TCR |
T-Cell Immunoglobulin Mucin-3 |
TIM-3 |
Transforming Growth Factor-Β |
TGF-Β |
Tumor-Associated Antigen |
TAA |
Tumor-Infiltrating Lymphocyte |
TIL |
Tumor-Associated Macrophage |
TAM |
Tumor Microenvironment |
TME |